Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dan Puckett, Thomas Musci, Francis deSouza, Doug Basset, Sherri Bale, More


Ariosa Diagnostics has promoted Dan Puckett to chief financial officer and Thomas Musci to chief medical officer.

Puckett joined Ariosa in Sept. 2011 as vice president of finance and administration and has helped develop the company's finance, accounting, purchasing, human resources, and facilities infrastructure.

Musci joined the company in May 2012 as vice president of clinical and medical affairs and has led the clinical development activities resulting in peer-reviewed, published articles. Additionally, he has helped grow the medical affairs department within Ariosa that provides genetic counseling and medical liaison expertise to the firm's clients.

Francis deSouza will join Illumina as president in December. He will report to CEO Jay Flatley and will lead Illumina's business units and the core functions responsible for envisioning, developing, and producing the company's products. He will also become part of Illumina's executive management team.

DeSouza joins Illumina from Symantec, where he is currently president of products and services. Prior to that, he held a variety of executive roles at Symantec, which he joined in 2006, when company acquired IMlogic, where he was co-founder and CEO. Before that, he was co-founder and CEO of Flash Communications, which was acquired by Microsoft. DeSouza holds MS and BS degrees in electrical engineering and computer science from the Massachusetts Institute of Technology.

Qiagen has formed an Ingenuity Scientific Advisory Board to help guide the development of its clinical interpretation and reporting solutions. Members include: Doug Basset, CTO and CSO at Qiagen, who will chair the board; Sherri Bale, managing director and cofounder of GeneDx and senior vice president of BioReference Laboratories; Hakon Hakonarson, director of the Center for Applied Genomics at the Children's Hospital of Philadelphia; Madhuri Hegde, executive director of Emory Genetics Laboratory; Elaine Mardis, co-director of the Genome Institute at Washington University; Eric Schadt, director of the Icahn Institute for Genomics and Multiscale Biology at Mt. Sinai Hospital; and Jay Shendure, associate professor of genome sciences at the University of Washington.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.